Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles

Maria Letizia Manca1, Giuseppe Loy, Marco Zaru

  • 1Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio 26510, Greece.

Insights

Chitosan-coated PLGA microparticles enhance rifampicin loading and mucoadhesion for nebulization. Coating modifies drug release kinetics, offering potential for improved pulmonary drug delivery.

Area of Science:

  • Materials Science
  • Pharmaceutical Sciences
  • Biotechnology

Background:

  • Rifampicin (RIF) delivery via microparticles (MPs) is explored for pulmonary applications.
  • Chitosan (CHT), PLGA, and CHT/PLGA mixtures were investigated for RIF-loaded MPs.
  • CHT-coated PLGA MPs demonstrated superior RIF-loading, nebulization, stability, and mucoadhesion.

Purpose of the Study:

  • To investigate the release kinetics of RIF from CHT, PLGA, and CHT/PLGA MPs.
  • To evaluate the influence of pH (4.40 and 7.40) on RIF release.
  • To assess the impact of CHT coating on PLGA MP drug release.

Main Methods:

  • Preparation and characterization of RIF-loaded MPs (CHT, PLGA, PLGA/CHT).
  • In vitro drug release studies in buffers at pH 4.40 and 7.40.
  • Assessment of RIF release profiles and kinetics.

Main Results:

  • CHT MPs showed higher burst release at pH 4.40 due to CHT solubility.
  • Crosslinking CHT with glutaraldehyde reduced burst release at pH 7.40.
  • RIF release from PLGA MPs was pH-independent, influenced by PVA stabilizer.
  • CHT coating on PLGA MPs increased RIF retention at pH 7.40 but accelerated release at pH 4.40.

Conclusions:

  • PLGA MPs coated with CHT exhibit modified RIF release kinetics.
  • CHT coating enhances mucoadhesive properties of PLGA MPs.
  • These findings suggest potential for optimized pulmonary drug delivery systems.